ALGS compared with SENS: revenue, margins and what each company keeps, and the suppliers and customers both name

ALGSAligos Therapeutics, Inc.

Mkt capRevenueRevenue

SENSSenseonics Holdings, Inc.

Mkt capRevenueRevenue

Compare

ALGSAligos Therapeutics, Inc.

SENSSenseonics Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ALGS2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▼−9.76%—

Q2 FY26—▲+16.24%—

SENS1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.6%▲+36.31%×3.13

= impliedALGS realized, solidSENS realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

ALGSAligos Therapeutics, Inc.

4.15▼−7.98%· post 4.15

Mkt cap$50.9MRevenue$3MQ3 FY26Revenue$2MFY25

SENSSenseonics Holdings, Inc.

8.57▲+7.25%· post 8.57

ClosedNov 6 '26

Mkt cap$454.2MRevenue$14MQ2 FY26Revenue$35MFY25

Compare

ClosedNov 6 '26

ALGSAligos Therapeutics, Inc.

SENSSenseonics Holdings, Inc.

4.15▼−7.98%post 4.15

Price

8.57▲+7.25%post 8.57

$50.9M

Mkt cap

$454.2M

Q3 FY26$3M

Revenue

$14MQ2 FY26

FY25$2M

Revenue

$35MFY25

ALGS4.15▼−7.98%vsSENS8.57▲+7.25%ClosedNov 6 '26